Dyslipidemia After Switch to TAF-Based cART in HIV Patients Dyslipidemia After Switch to TAF-Based cART in HIV Patients

Switching from tenofovir to tenofovir alafenamide may cause lipid profile changes in HIV patients. What are the clinical implications?HIV Medicine
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news